151 related articles for article (PubMed ID: 30445600)
1. TIPE1 promotes cervical cancer progression by repression of p53 acetylation and is associated with poor cervical cancer outcome.
Zhao P; Pang X; Jiang J; Wang L; Zhu X; Yin Y; Zhai Q; Xiang X; Feng F; Xu W
Carcinogenesis; 2019 Jun; 40(4):592-599. PubMed ID: 30445600
[TBL] [Abstract][Full Text] [Related]
2. TIPE1-mediated autophagy suppression promotes nasopharyngeal carcinoma cell proliferation via the AMPK/mTOR signalling pathway.
Liu Y; Qi X; Zhao Z; Song D; Wang L; Zhai Q; Zhang X; Zhao P; Xiang X
J Cell Mol Med; 2020 Aug; 24(16):9135-9144. PubMed ID: 32588529
[TBL] [Abstract][Full Text] [Related]
3. EBF1-Mediated Upregulation of Ribosome Assembly Factor PNO1 Contributes to Cancer Progression by Negatively Regulating the p53 Signaling Pathway.
Shen A; Chen Y; Liu L; Huang Y; Chen H; Qi F; Lin J; Shen Z; Wu X; Wu M; Li Q; Qiu L; Yu N; Sferra TJ; Peng J
Cancer Res; 2019 May; 79(9):2257-2270. PubMed ID: 30862720
[TBL] [Abstract][Full Text] [Related]
4. miR-587 promotes cervical cancer by repressing interferon regulatory factor 6.
Ren Y; Dong J; He P; Liang Y; Wu L; Wang J; Chu B
J Gene Med; 2020 Nov; 22(11):e3257. PubMed ID: 32749750
[TBL] [Abstract][Full Text] [Related]
5. TIPE1 Promotes Cervical Cancer Cell Chemoresistance to Cisplatin in a Wild-Type p53-Dependent Manner.
Jiang J; Gao L; Lan Y; Wang Y; Zhao P
Front Oncol; 2020; 10():593615. PubMed ID: 33520705
[TBL] [Abstract][Full Text] [Related]
6. Regulation of p53 expression and apoptosis by vault RNA2-1-5p in cervical cancer cells.
Kong L; Hao Q; Wang Y; Zhou P; Zou B; Zhang YX
Oncotarget; 2015 Sep; 6(29):28371-88. PubMed ID: 26318295
[TBL] [Abstract][Full Text] [Related]
7. Cyclin-dependent kinase 9 promotes cervical cancer development via AKT2/p53 pathway.
Xu J; Xu S; Fang Y; Chen T; Xie X; Lu W
IUBMB Life; 2019 Mar; 71(3):347-356. PubMed ID: 30536701
[TBL] [Abstract][Full Text] [Related]
8. FAM3B promotes progression of oesophageal carcinoma via regulating the AKT-MDM2-p53 signalling axis and the epithelial-mesenchymal transition.
He SL; Wang WP; Yang YS; Li EM; Xu LY; Chen LQ
J Cell Mol Med; 2019 Feb; 23(2):1375-1385. PubMed ID: 30565387
[TBL] [Abstract][Full Text] [Related]
9. Msi1 promotes tumor growth and cell proliferation by targeting cell cycle checkpoint proteins p21, p27 and p53 in cervical carcinomas.
Liu X; Yang WT; Zheng PS
Oncotarget; 2014 Nov; 5(21):10870-85. PubMed ID: 25362645
[TBL] [Abstract][Full Text] [Related]
10. A Novel cytarabine analog evokes synthetic lethality by targeting MK2 in p53-deficient cancer cells.
Song J; Yu J; Jeong LS; Lee SK
Cancer Lett; 2021 Jan; 497():54-65. PubMed ID: 33075425
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of hnRNP A2/B1 inhibits cell proliferation, invasion and cell cycle triggering apoptosis in cervical cancer via PI3K/AKT signaling pathway.
Shi X; Ran L; Liu Y; Zhong SH; Zhou PP; Liao MX; Fang W
Oncol Rep; 2018 Mar; 39(3):939-950. PubMed ID: 29328485
[TBL] [Abstract][Full Text] [Related]
12. Guanosine monophosphate synthase upregulation mediates cervical cancer progression by inhibiting the apoptosis of cervical cancer cells via the Stat3/P53 pathway.
Wang J; Wu Y; Li Y; Wang Y; Shen F; Zhou J; Chen Y
Int J Oncol; 2021 Apr; 58(4):. PubMed ID: 33649833
[TBL] [Abstract][Full Text] [Related]
13. Natural killer T cell cytotoxic activity in cervical cancer is facilitated by the LINC00240/microRNA-124-3p/STAT3/MICA axis.
Zhang Y; Li X; Zhang J; Liang H
Cancer Lett; 2020 Apr; 474():63-73. PubMed ID: 31904481
[TBL] [Abstract][Full Text] [Related]
14. TIPE1 impairs stemness maintenance in colorectal cancer through directly targeting β-catenin.
Ye T; Yang B; Wang C; Su C; Luo J; Yang X; Yu H; Yuan Z; Meng Z; Xia J
Carcinogenesis; 2020 Mar; 41(1):25-35. PubMed ID: 31111874
[TBL] [Abstract][Full Text] [Related]
15. SNRPB promotes cervical cancer progression through repressing p53 expression.
Zhu L; Zhang X; Sun Z
Biomed Pharmacother; 2020 May; 125():109948. PubMed ID: 32106364
[TBL] [Abstract][Full Text] [Related]
16. Tanshinone IIA inhibits viral oncogene expression leading to apoptosis and inhibition of cervical cancer.
Munagala R; Aqil F; Jeyabalan J; Gupta RC
Cancer Lett; 2015 Jan; 356(2 Pt B):536-46. PubMed ID: 25304375
[TBL] [Abstract][Full Text] [Related]
17. Slug inhibits the proliferation and tumor formation of human cervical cancer cells by up-regulating the p21/p27 proteins and down-regulating the activity of the Wnt/β-catenin signaling pathway via the trans-suppression Akt1/p-Akt1 expression.
Cui N; Yang WT; Zheng PS
Oncotarget; 2016 May; 7(18):26152-67. PubMed ID: 27036045
[TBL] [Abstract][Full Text] [Related]
18. Regulation of the epithelial to mesenchymal transition and metastasis by Raf kinase inhibitory protein-dependent Notch1 activity.
Noh HS; Hah YS; Ha JH; Kang MY; Zada S; Rha SY; Kang SS; Kim HJ; Park JY; Byun JH; Hahm JR; Shin JK; Jeong SH; Lee YJ; Kim DR
Oncotarget; 2016 Jan; 7(4):4632-46. PubMed ID: 26716415
[TBL] [Abstract][Full Text] [Related]
19. Hypermethylation of Single CpG Dinucleotides at the Promoter of CXCL13 Gene Promoting Cell Migration in Cervical Cancer.
Ma D; Fan SB; Hua N; Li GH; Chang Q; Liu X
Curr Cancer Drug Targets; 2020; 20(5):355-363. PubMed ID: 31899677
[TBL] [Abstract][Full Text] [Related]
20. Angiogenic factor AGGF1 acts as a tumor suppressor by modulating p53 post-transcriptional modifications and stability via MDM2.
Si W; Zhou B; Xie W; Li H; Li K; Li S; Deng W; Shi P; Yuan C; Ke T; Ren X; Tu X; Zeng X; Weigelt B; Rubin BP; Chen Q; Xu C; Wang QK
Cancer Lett; 2021 Jan; 497():28-40. PubMed ID: 33069768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]